Search

Your search keyword '"Vincristine -- Forecasts and trends -- Market size"' showing total 6 results
Start Over Descriptor "Vincristine -- Forecasts and trends -- Market size"
6 results on '"Vincristine -- Forecasts and trends -- Market size"'

1. Ewing's Sarcoma Treatment Market to Grow by USD 205.09 Million (2024-2028), Awareness and Funding Drive Growth, AI-Powered Report on Market Trends - Technavio

Subjects
Company growth, Market trend/market analysis, Sarcoma -- Drug therapy, Vincristine -- Forecasts and trends -- Market size
Abstract

NEW YORK, Dec. 13, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global http://www.technavio.com/report/ewings-sarcoma-treatment-market-industry-size-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=ai_driver_report_week50_2024&utm_content=IRTNTR72933 size is estimated to grow by USD 205.09 million from 2024-2028, [...]

Published
2024

2. Ewing's Sarcoma Treatment Market to Grow by USD 205.09 Million (2024-2028), Driven by Increased Awareness and Funding, AI Impacting Market Trends - Technavio

Subjects
Sarcoma -- Drug therapy, Vincristine -- Forecasts and trends -- Market size, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: Report on how AI is redefining market landscape - The global ewing's sarcoma treatment market size is estimated to grow by [...]

Published
2024

3. Ewing's Sarcoma Treatment Market to Grow by USD 205.09 Million (2024-2028), Driven by Increased Awareness and Funding, AI Impacting Market Trends - Technavio

Subjects
Sarcoma -- Drug therapy, Vincristine -- Forecasts and trends -- Market size, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, Nov. 22, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global http://www.technavio.com/report/ewings-sarcoma-treatment-market-industry-size-analysis?utm_source=prnewswire&utm_medium=pressrelease&utm_campaign=ai_trend_v2_report_week47_2024&utm_content=IRTNTR72933 size is estimated to grow by USD 205.09 million from 2024-2028, [...]

Published
2024

4. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, Gilead Sciences Inc. -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Novartis AG -- Forecasts and trends, Biological products industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Lymphomas -- Forecasts and trends, Vincristine -- Forecasts and trends -- Market size, Radiotherapy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, General interest, News, opinion and commentary
Abstract

NEW YORK: Technavio has issued the following news release: The global diffuse large B-cell lymphoma (DLBCL) therapeutics market size is estimated to grow by USD 2.24 billion from 2024-2028, according [...]

Published
2024

5. Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market size is set to grow by USD 2.24 billion from 2024-2028, Growing geriatric population boost the market, Technavio

Subjects
ADC Therapeutics S.A. -- Forecasts and trends, Amgen Inc. -- Forecasts and trends, Bayer AG -- Forecasts and trends, AbbVie Inc. -- Forecasts and trends, Bristol-Myers Squibb Co. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Patient compliance -- Forecasts and trends, Biotechnology industry -- Forecasts and trends, Lymphomas -- Forecasts and trends, Vincristine -- Forecasts and trends -- Market size, Radiotherapy -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

NEW YORK, June 27, 2024 /PRNewswire/ -- The global diffuse large B-cell lymphoma (DLBCL) therapeutics market size is estimated to grow by USD 2.24 billion from 2024-2028, according to Technavio. [...]

Published
2024

6. Diffuse Large B-Cell Lymphoma Market expected to rise | Companies - AbbVie and Genmab, Merck, Roche, Xencor and Janssen, Denovo Biopharma, Calithera Biosciences, IMV, Biogen, Autolus Therapeutics

Subjects
Merck & Company Inc. -- Forecasts and trends, Biological products industry -- Forecasts and trends, Non-Hodgkin's lymphomas -- Forecasts and trends, B cells -- Forecasts and trends, Vincristine -- Forecasts and trends -- Market size, Brand equity -- Forecasts and trends, Epidemiology -- Forecasts and trends, Pharmaceutical industry -- Forecasts and trends, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-June 20, 2023-: Diffuse Large B-Cell Lymphoma Market expected to rise | Companies - AbbVie and Genmab, Merck, Roche, Xencor and Janssen, Denovo Biopharma, Calithera Biosciences, IMV, Biogen, Autolus [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results